PharmAthene, Inc. PIP was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the past one month's volatile price range of $1.38 to $1.45.
This biodefense company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Friday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
PharmAthene currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the Medical Drugs industry are Spectrum Pharmaceuticals, Inc. SPPI, Ariad Pharmaceuticals Inc. ARIA and BioCryst Pharmaceuticals, Inc. BCRX. While SPPI sports a Zacks Rank #1 (Strong Buy), ARIA and BCRX bear a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ARIAD PHARMA ARIA: Free Stock Analysis Report
BIOCRYST PHARMA BCRX: Free Stock Analysis Report
PHARMATHENE INC PIP: Get Free Report
SPECTRUM PHARMA SPPI: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
